Clinical Trial Update: Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating oxaliplatin, leucovorin, and fluorouracil with or without bevacizumab as adjuvant therapy after surgery for Stage II colon cancer has p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Adenocarcinoma
• Colon Cancer

Drugs mentioned

• Adrucil (5-fluorouracil)
• Avastin (bevacizumab)
• Eloxatin (oxaliplatin)
• Fusilev (Leucovorin)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Colon Adenocarcinoma, Stage IIA Colon Cancer AJCC v7 | Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-07-20